Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Double Point Ventures
Double Point Ventures

Double Point Ventures

Florida-based Double Point Ventures invests in innovative companies pioneering in therapeutics and precision medicines.

HQ
Palm Beach, FL, US
Overview
Compare
Employees

Double Point Ventures, based in Palm Beach, Florida, is dedicated to investing in revolutionary companies that are developing cutting-edge therapeutics, including gene therapies and precision medicines. The firm's core mission is to support and accelerate the growth of innovative healthcare solutions that have the potential to transform patient outcomes. By focusing on high-impact areas within the biotechnology and pharmaceutical sectors, Double Point Ventures aims to foster advancements that address unmet medical needs.

Notable affiliated individuals and investors include seasoned professionals from the biotech and investment communities, bringing a wealth of experience and strategic insight to the firm. Double Point Ventures has achieved significant milestones by backing companies that have made groundbreaking progress in therapeutic development. Their investments have catalyzed advancements in precision medicine, contributing to the overall impact of improving healthcare and patient care on a global scale.

Double Point Ventures - Similar Companies

curative ventures logo

curative ventures

Bioventure Partners logo

Bioventure Partners

Ventura BioMed Investors logo

Ventura BioMed Investors

ventura-biomed.com

DeciBio Ventures logo

DeciBio Ventures

Pathway Bioventures logo

Pathway Bioventures

Lifespan Vision Ventures logo

Lifespan Vision Ventures

Double Point Ventures - Quick Facts

Who are Double Point Ventures' competitors?

Companies similar to Double Point Ventures include curative ventures, Bioventure Partners, Ventura BioMed Investors and DeciBio Ventures.

Where is Double Point Ventures' headquarters located?

Double Point Ventures' headquarters is located in Palm Beach, FL, US.

How many employees does Double Point Ventures have?

Double Point Ventures has 5 employees as of Feb 4, 2024.

Double Point Ventures - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Medicines
  • Therapeutics
Tags
  • Financial
  • Healthtech